Results 101 to 110 of about 341,328 (259)

Cryotherapy as Treatment for Chronic Rhinitis: Long‐Term Results of a Prospective, Multicenter Registry

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective The purpose of this registry was to capture observational data on a large and diverse cohort treated with the ClariFix Cryotherapy device for chronic rhinitis. Study Design Prospective, multicenter, nonrandomized, observational registry. Setting Twenty‐two tertiary care and private otolaryngology practices. Methods ClariFix treatment
Amber U. Luong, Neelesh H. Mehendale, Emily Szabo, Farhad Sigari, Anthony G. Del Signore, David M. Yen   +5 more
wiley   +1 more source

Acupuncture for nasal congestion in COVID-19: A protocol for systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2022
Dong Z, Guo J, Deng T, Zhang J, Lv X, Zhang K, Ma Y, Ma Y.   +7 more
europepmc   +1 more source

Relationship between Nasal Congestion and Quality of Life of Allergic Rhinitis Patients [PDF]

Nasal congestion is the most common complaint complained of by allergic rhinitis sufferers. Symptoms of nasal congestion in allergic rhinitis can affect a person's quality of life, resulting in decreased work productivity, academic and social success ...
Lutfiyani, Ida Zulfa, Tjahyadewi, Shelly, Rahayu, Rahayu, Sardjana, Andriana Tjitria Widi Wardani, Masfiyah, Masfiyah   +4 more
core   +1 more source

Toxoplasma gondii Infection After Kidney Transplantation: A Case Report and Literature Review

Organ Medicine, EarlyView.
Toxoplasma gondii infection after kidney transplantation is rare and presents with nonspecific clinical manifestations; however, the associated mortality rate is high. We discuss the relevant literature, clinical manifestations, therapeutic regimens, and prognoses of post‐transplantation toxoplasmosis.
Peng Zhang, Xingqiang Lai, Rongxin Chen, Li Li, Jiali Fang, Guanghui Li, Junjie Ma, Luhao Liu, Zheng Chen   +8 more
wiley   +1 more source

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

Phytotherapy Research, EarlyView.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit, Aylin Bülbül, Betul Kocaadam‐Bozkurt, Osman Bozkurt, Duygu Ağagündüz, Raffaele Capasso   +5 more
wiley   +1 more source

Treatment of congestion in upper respiratory diseases

, 2010
Eli O Meltzer1, Fernan Caballero2, Leonard M Fromer3, John H Krouse4, Glenis Scadding51Allergy and Asthma Medical Group and Research Center, San Diego, CA and Department of Pediatrics, University of California, San Diego, USA; 2Allergy and Clinical ...
Fernan Caballero, Leonard M Fromer, et al, Eli O Meltzer   +3 more
core  

Benefits and Harms of Herbal Medicines for Preventing and Treating Acute Respiratory Infections: An Overview of Systematic Reviews

Phytotherapy Research, EarlyView.
Overview of systematic reviews evaluating the benefits and harms of herbal medicines for management of ARIs. ABSTRACT Hundreds of herbal medicines are currently marketed for the management of acute respiratory infections (ARIs). However, there is uncertainty about their benefits and harms, and clinical guidance remains unclear.
Fariba Aghajafari, Brian Choi, Devansh Bhatt, Susanna Maltoni, Elizabeth T. Thomas, Elena C. Rosca, Sara Gandini, Annette Plüddemann, Carl J. Heneghan, John M. Conly, Tom Jefferson, Igho J. Onakpoya   +11 more
wiley   +1 more source

Part 1 - imidazolines and the changing face of nasal decongestants

Frontiers in Pharmacology
Imidazolines are sympathomimetic drugs used to treat a range of conditions including nasal congestion, ocular disorders, and hypertension. Imidazolines were discovered over 150 years ago.
Rebecca J. Stinson, Laura R. Sadofsky
doaj   +1 more source

The course of COVID-19 infection and prolonged sneezing and nasal congestion in a patient using ixekizumab. [PDF]

Dermatol Ther, 2021
Güder S, Güder H.
europepmc   +1 more source

Mometasone furoate nasal spray for nasal polyposis

, 2007
Nasal polyposis occurs in 2-4% of the general population and is associated with significant socioeconomic costs due to severe nasal/airway symptoms that impair quality of life.
Stjärne, P,
core   +1 more source